SEC Form 4 · accession 0001415889-16-004340
Medovex Corp. · MDVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jarrett S Gorlin
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Jan 6, 2016
Accepted (ET)
Jan 8, 2016 · 1:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001591165
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Purchase Common StockF1 | $0.95 | Jan 6, 2016 | A | 40,800 | A | — | Jan 6, 2026 | Common Stock | 40,800 | 40,800 | D |
Explanation of responses
- F1The options shall vest and become exercisable in four (4) installments as follows: the first installment to purchase 25% of the common stock underlying the options, or the right to purchase 10,200 shares, vested on January 6, 2016 and the balance of the options, or the right to purchase 30,600 shares shall vest in three equal installments on January 6, 2017, January 6, 2018 and January 6, 2019.